Prolastin Articles
Allergan Announces R&D Pipeline Developments
5 May 1997
Synthelabo Presents 1996 Highlights, New Research
21 April 1997
Chiron Submits BLA For Proleukin
21 April 1997
Lamivudine Improves Liver Histology In Hepatitis B
21 April 1997
Synthelabo Seeking Merger; New Strategic Plan
10 April 1997
Enhanced R&D And Global Expansion At Eisai
7 April 1997
Merck & Co's Propecia Shows Promise In Hair Loss
26 March 1997
Bayer Pharma Starts New Product Cycle
20 March 1997
British Biotech Pipeline Close To Bearing First Fruit
17 March 1997
First Approval Of 3M's Genital Wart Product
10 March 1997
Verigen's Anti-TNF Drug For Arthritis
3 March 1997
PPL Clones First Mammal From Adult Cells
3 March 1997
Celltech's CDP571 Shows Promise In Crohn's
3 March 1997
Forecasts To 2002 For Euro Biotech Pharma Market
17 February 1997
Bone Care's One-Alpha D2 "Safe And Effective" In Ph II
17 February 1997
Genetics Institute's Factor IX Approved In 1st Market
17 February 1997
South African AIDS "Cure" Conjures Up Kemron Myth
17 February 1997
Significant Increases For US Drug Firms In 1996
3 February 1997
US 4th Qtr/Year-End Results See Strong Growth
27 January 1997
Medeva Takes On Single Isomer Methylphenidate
27 January 1997
DSM May Acquire Control Of India's Alpha Drugs
27 January 1997
Record Number Of New Chemical Entities In 1996
20 January 1997
Bayer's Miglitol Gains Approval In USA
20 January 1997
ALRT Presents New Drug Candidates At H&Q
20 January 1997
SciClone Reports New Data With Zadaxin
6 January 1997
Product News In 1996 Dominated By CNS
23 December 1996
First Launch Of SciClone's Zadaxin In China
9 December 1996
Merck Acquires Bone Substitute
9 December 1996
FDA Approves Elan's Zanaflex For Spasticity
9 December 1996
Companies Move On Hemophiliacs' HIV Settlement
9 December 1996
Boeh Mannheim Starts Anti-HBV Trials
2 December 1996
SciClone's Zadaxin "Effective" In HCV
18 November 1996
Alizyme Details R&D Strategy And Pipeline
18 November 1996
Acquisitions Boost Fresenius' Results
18 November 1996
First Approval for Miglitol In Holland
11 November 1996
Promising Data With Maxim's Maxamine
4 November 1996
Cytel And Nextran To Develop Xenotransplant Product
28 October 1996
Structure Of Hep C Protease Solved; On Your Marks]
28 October 1996
Alpha-Beta Technology Start Phase II With Betafectin
21 October 1996
Synthelabo Pipeline Supports "Seven Key Product" Strategy
21 October 1996
EU Approves Baxter's Takeover Of Immuno
21 October 1996
Combination Therapy For HCV; Zadaxin
14 October 1996
New Hepatitis Treatments Highlighted At ICAAC
7 October 1996
Do Vaccination Schedules Alter The Risk Of Diabetes?
30 September 1996
MIDAS Trial Reopens Ca Channel Blocker Debate
16 September 1996
First Launch Of Carvedilol For CHF; Approval In Spain
2 September 1996
Green Cross Offices Raided
2 September 1996
Terazosin Superior To Finasteride For BPH
2 September 1996
Receptors Support Amyloid Theory Of Alzheimer's
2 September 1996
CTI Begins Phase III With Lisofylline
19 August 1996
Profits At Fresenius Up 51% In First Half
19 August 1996
New Study Of ISIS-3521
12 August 1996
Stepwise Progress Towards Septic Shock Treatment
12 August 1996
Phase III For Progenics' Cancer Vaccine
12 August 1996
"Excellent" 1st Half For Zeneca But Share Price Falls
12 August 1996
Single-Digit Profits Growth For B-MS And W-L
5 August 1996
HIV Co-Receptors; Basis For Treatment?
29 July 1996
First Launch Of Organon's Puregon
22 July 1996
SciClone's Zadaxin For HIV
22 July 1996
First Market Launch of Serdolect
15 July 1996
Philippines Appro For SciClone's Zadaxin
1 July 1996
Organon's Remeron Cleared In USA
24 June 1996
First Approval For Novel Glaucoma Drug
24 June 1996
Tamsulosin Launches
24 June 1996
Results Of Geneda Corp's B-2 Actigen Pilot Study
17 June 1996
Business Strengthened In 1995 At GeneMedicine
17 June 1996
Schering-Plough Forecasts 15% EPS Rise For 1996
10 June 1996
US Patent Issued To Interferon Sciences
10 June 1996
Schering-Plough Chief Gives R&D Update
10 June 1996
Sales Growth At Yamanouchi Led By Gaster
10 June 1996
P&U Moves To Revamp Inherited Pipeline
3 June 1996
EMEA Approves Three More Products
3 June 1996
VA Study Rates Hytrin Over Proscar
13 May 1996
EMEA: Experiences Of The First Year
6 May 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Health Insurers In Massachusetts To Pay For AIDS Drugs
22 April 1996
New Regimen For Intron A In Hep C
15 April 1996
Bayer Details Near-Term Product Expectations
1 April 1996
Fresenius On The Verge Of Major Changes
25 March 1996
EMEA 1995-95: A Crucial Period of Transition
25 March 1996
Results From Taiwanese Zadaxin Study
18 March 1996
Alpha-Beta Offering
18 March 1996
US Clearance For Biogen's Avonex Expected Soon
18 March 1996
Athena Starts MS Trials In UK
11 March 1996
Bayer Launches Acarbose In Canada
11 March 1996
Viragen's Interferon In Trials
11 March 1996
Atlantic: Epitomizing The "Virtual" Firm Concept
11 March 1996
Alpha-Beta Offering
4 March 1996
Maxim's EpiLeukin For AML
4 March 1996
Ciba Expands Deal With Isis On Antisense
26 February 1996
ABC's Cytokine Remover In Trials
26 February 1996
Alpha 1 Biomedicals Suspends CF Drug
19 February 1996
World Markets: Cancer, Cardiovascular, Menopause
19 February 1996
EMEA Reports Successes In Inaugural 1995
5 February 1996
Clotting Factor Products Transmit Hep A Virus
29 January 1996
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
